News & Updates

NAC protects against chemo-induced neuropathy

19 Mar 2025

Treatment with oral N-acetylcysteine (NAC) 1,200 mg/day does not result in a significant reduction in the incidence or severity of chemotherapy-induced peripheral neuropathy (CIPN) in patients with breast cancer, a recent study has shown.

NAC protects against chemo-induced neuropathy

19 Mar 2025

D-dimer predicts clinical outcomes in N. meningitidis infections

19 Mar 2025 by

Increasing D-dimer is a useful predictor of negative clinical outcomes among individuals with invasive infections driven by Neisseria Meningitidis, suggests a study.

D-dimer predicts clinical outcomes in N. meningitidis infections

19 Mar 2025

GLP-1 RA use before endoscopy tied to low retained gastric contents

19 Mar 2025

Patients taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs), particularly those with type 2 diabetes (T2D), have very low rates of retained gastric contents during endoscopy, as shown in a study.

GLP-1 RA use before endoscopy tied to low retained gastric contents

19 Mar 2025

Managing advanced colorectal cancer with robotic surgery

19 Mar 2025 by

In colorectal cancer, the traditional method for removing the tumour is open surgery. However, the surgical treatment landscape has evolved over the years and transitioned to embrace the utilization of minimally invasive approaches such as laparoscopic or keyhole surgery and the use of robotics.

Managing advanced colorectal cancer with robotic surgery

19 Mar 2025

Light movement in lieu of sedentary time improves cardiometabolic outcomes

19 Mar 2025 by

Data from the CARDIA study demonstrate that replacing sedentary time with light-intensity physical activity (LPA) is associated with improved cardiometabolic outcomes.

Light movement in lieu of sedentary time improves cardiometabolic outcomes

19 Mar 2025

Long-term oral progestogen therapy effective, well tolerated in endometriosis management

19 Mar 2025 by

Endometriosis is a chronic disease, which requires interventions that are both effective and well tolerated in the long term. Dr Tak-Keung Sum, Specialist in Obstetrics and Gynaecology in private practice in Hong Kong, reviews clinical and real-world evidence on the long-term efficacy and safety of an oral progestogen, dienogest (Visanne^®, Bayer), and shares his personal experience in managing endometriosis across different patient profiles.

Long-term oral progestogen therapy effective, well tolerated in endometriosis management

19 Mar 2025

4 in 10 adults with chronic pain face mental health woes

18 Mar 2025 by

Chronic pain is accompanied by depression and anxiety in 40 percent of adults, according to the results of a meta-analysis.

4 in 10 adults with chronic pain face mental health woes

18 Mar 2025

Probiotics help relieve chemo-induced diarrhoea

18 Mar 2025

The use of probiotics leads to a significant reduction in chemotherapy-related diarrhoea, suggesting its potential as supportive care agent in oncology, according to a study.